Rousseff’s exit: a boost for Brazil?

With Brazil's president Dilma Rousseff dismissd by the senate, the country is hoping for a "shock of capitalism". Here are two of the best ways ways to buy in.

"We are hoping for a shock of capitalism' in the next two years," the head of the Brazilian stock exchange, Edemir Pinto, told the FT. Brazil's president Dilma Rousseff was dismissed from office last week by a vote in the Senate, and will be replaced by Michel Temer, "whose talk of privatisation, deregulation and fiscal discipline has cheered investors", says The Economist.

Rousseff was convicted of manipulating the national budget, but will be remembered primarily for presiding over, and compounding, Brazil's worst recession in over a century. The economy shrank by an annual 5.4% and 3.8% in the first and second quarters respectively. The end of the commodities boom has dented exports, but Rousseff's government hardly helped. It overspent wildly the annual deficit has reached 10% of GDP micromanaged, propped up favoured industries, and leant on the central bank to cut interest rates when inflation was far from under control.

Subscribe to MoneyWeek

Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE

Get 6 issues free
https://cdn.mos.cms.futurecdn.net/flexiimages/mw70aro6gl1676370748.jpg

Sign up to Money Morning

Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter

Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter

Sign up
Andrew Van Sickle
Editor, MoneyWeek

Andrew is the editor of MoneyWeek magazine. He grew up in Vienna and studied at the University of St Andrews, where he gained a first-class MA in geography & international relations.

After graduating he began to contribute to the foreign page of The Week and soon afterwards joined MoneyWeek at its inception in October 2000. He helped Merryn Somerset Webb establish it as Britain’s best-selling financial magazine, contributing to every section of the publication and specialising in macroeconomics and stockmarkets, before going part-time.

His freelance projects have included a 2009 relaunch of The Pharma Letter, where he covered corporate news and political developments in the German pharmaceuticals market for two years, and a multiyear stint as deputy editor of the Barclays account at Redwood, a marketing agency.

Andrew has been editing MoneyWeek since 2018, and continues to specialise in investment and news in German-speaking countries owing to his fluent command of the language.